Get Sylvant (Siltuximab) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide 2025
Answer Box: Fast Track to Sylvant Coverage
Yes, Blue Cross Blue Shield covers Sylvant (siltuximab) in New Jersey for FDA-approved idiopathic multicentric Castleman disease (iMCD), but prior authorization is required. Your fastest path: (1) Ensure you have documented HIV-negative and HHV-8-negative test results, (2) Have your physician submit the PA